Clinical Trial Update: A Study In Adults With Moderate To Severe Dermatomyositis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in adults with moderate to severe dermatomyositis completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Snippet

Sponsor: Pfizer | Conditions: Dermatomyositis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-14